or Try an Advanced Search...

    Glucagon Like Peptide 1 Stocks List

    Symbol Grade Name % Change
    VANI D Vivani Medical, Inc. 0.04
    NVO D Novo Nordisk A/S -3.16
    ORMP F Oramed Pharmaceuticals Inc. 2.54
    THNR F Amplify Weight Loss Drug & Treatment ETF 0.00
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Diabetes Peptide Hormones Endocrine System Insulin Medicine Anti Diabetic Drugs Biopharmaceutical Chronic Disease Diabetes Care Gastrointestinal Glucagon Growth Hormone Growth Hormone Therapy Haemophilia Hormone Therapy Hormones Implant Inflammation Integrated Security Life Sciences

    Related ETFs - A few ETFs which own one or more of the above listed Glucagon Like Peptide 1 stocks.

    Symbol Grade Name Weight
    OZEM F Roundhill GLP-1 & Weight Loss ETF 17.04
    THNR F Amplify Weight Loss Drug & Treatment ETF 13.16
    PPH D Market Vectors Pharmaceutical ETF 7.69
    BELT B BlackRock Long-Term U.S. Equity ETF 5.28
    AADR A WCM BNY Mellon Focused Growth ADR ETF 4.85
    View all Glucagon Like Peptide 1 ETFs...
    Compare ETFs
    Compare OZEM to BELT Compare OZEM to THNR Compare PPH to BELT

        Glucagon Like Peptide 1 Stocks Recent News

        Date Stock Title
        Nov 20 NVO More companies covering weight loss drugs for their employees
        Nov 20 NVO Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
        Nov 20 NVO Is Novo Nordisk Stock a Buy Right Now?
        Nov 20 NVO RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
        Nov 19 NVO Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
        Nov 19 NVO Sector Update: Health Care Stocks Decline
        Nov 19 NVO Novo Nordisk Unusual Options Activity For November 19
        Nov 19 NVO Sector Update: Health Care Stocks Mixed Tuesday Afternoon
        Nov 19 NVO Novo Erases 2024 Gain, Wiping Out $210 Billion in Value
        Nov 19 NVO Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
        Nov 19 NVO Employers Get Pressure to Pay for Drugs Like Wegovy
        Nov 18 NVO RFK Jr.'s HHS nomination sparks concern over pharma stocks
        Nov 18 NVO Novo Nordisk reportedly launches Wegovy in China
        Nov 18 NVO How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
        Nov 18 NVO Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
        Nov 18 NVO Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
        Nov 16 NVO The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
        Nov 16 VANI Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares
        Nov 15 NVO Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
        Nov 15 NVO Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Diabetes Peptide Hormones Endocrine System Insulin Medicine Anti Diabetic Drugs Biopharmaceutical Chronic Disease Diabetes Care Gastrointestinal Glucagon Growth Hormone Growth Hormone Therapy Haemophilia Hormone Therapy Hormones Implant Inflammation Integrated Security Life Sciences
        Glucagon Like Peptide 1

        Glucagon-like peptide 1 (GLP-1) is a hormone that is produced in the gut and released in response to food intake. It stimulates insulin secretion, suppresses glucagon secretion, slows gastric emptying, and increases satiety. GLP-1 is a key regulator of glucose homeostasis and is used as a treatment for type 2 diabetes.

        Browse All Tags